OxyElite Pro Warning

1princesswarrior

Copied from a warning sent to employees:

This email is sent on behalf of the Air Force Surgeon General Public Affairs
Office:

All Airmen urged to heed FDA warning about dietary supplements.

The U.S. Food and Drug Administration is advising consumers to stop using
OxyElite Pro, a dietary supplement, because of suspected links to acute
hepatitis.

The FDA, along with the Centers for Disease Control and Prevention and the
Hawaii Department of Health are investigating reports of acute non-viral
hepatitis in Hawaii where 29 cases are linked to a dietary supplement.

The FDA urges consumers to stop using the product while the investigation
continues. Distributed by USPlabs LLC in Dallas, Texas, the product is sold
nationwide in retail stores and on the internet. "We are urging Airmen to
stop using the product until the investigation concludes and results are
confirmed," said Col. John Oh, chief of Health Promotion, Air Force Medical
Support Agency, Air Force Surgeon General.

There have been a total of 29 cases of acute non-viral hepatitis with an
unknown cause reported in Hawaii. Eleven of the 29 patients have been
hospitalized with acute hepatitis, two have received liver transplants and
one person has died. The CDC is also investigating other cases of liver
injury nation-wide that could be related.

Symptoms of hepatitis include fever, fatigue, loss of appetite, nausea,
vomiting, abdominal pain, dark urine, clay or gray-colored bowel movements,
joint pain, yellow eyes, and jaundice.

Airmen who are experiencing these symptoms should contact their health care
provider immediately. Many Airmen reportedly use dietary supplements for
weight loss or muscle building. In 2011, one-third of Airmen reported using
legal bodybuilding supplements in the past year, including 15 percent in the
last month.

We encourage Airmen to get educated on dietary supplement safety through
Operation Supplement Safety, the Department of Defense dietary supplement
education and safety campaign. Information about the campaign is found at:
www.hprc-online.org/opss. Visit this link for more information about the FDA
warning:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMed
icalProducts/ucm370857.htm .

socioseguro

Thank you for sharing